Fifth Third Bancorp Has $739,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Fifth Third Bancorp increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 8,465 shares of the medical device company’s stock after acquiring an additional 502 shares during the period. Fifth Third Bancorp’s holdings in Cooper Companies were worth $739,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in COO. Vanguard Group Inc. raised its holdings in Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares during the period. Capital World Investors lifted its holdings in shares of Cooper Companies by 301.7% during the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after buying an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC boosted its position in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after acquiring an additional 2,532,186 shares during the period. Bessemer Group Inc. grew its stake in shares of Cooper Companies by 305.2% in the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after acquiring an additional 1,507,049 shares during the last quarter. Finally, Champlain Investment Partners LLC increased its position in Cooper Companies by 295.3% during the first quarter. Champlain Investment Partners LLC now owns 1,741,120 shares of the medical device company’s stock worth $176,654,000 after acquiring an additional 1,300,620 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Up 0.5 %

Shares of COO opened at $94.11 on Friday. The stock’s fifty day simple moving average is $90.80 and its 200-day simple moving average is $94.00. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $18.74 billion, a PE ratio of 55.36, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $104.07.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The business had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. During the same period last year, the company earned $0.77 EPS. The firm’s revenue was up 7.4% on a year-over-year basis. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have issued reports on COO shares. Piper Sandler restated an “overweight” rating and issued a $115.00 price target on shares of Cooper Companies in a research report on Wednesday, July 3rd. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Finally, Robert W. Baird upped their target price on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $111.78.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.